|
| Press Releases |
|
 |
|
| Friday, March 29, 2024 |
|
|
Sino Biopharm (1177.HK) Announces 2023 Annual Results |
| Sino Biopharmaceutical Limited ("Sino Biopharm" or the "Company", together with its subsidiaries, the "Group") (HKEX:1177), a leading innovation-driven pharmaceutical conglomerate in the PRC, has announced its audited financial results for the year ended 31 December 2023. more info >> |
|
| Friday, August 25, 2023 |
|
|
中国生物制药（1177.HK）公布2023中期业绩 |
| 中国领先的创新研发驱动型医药集团—中国生物制药有限公司（「中国生物制药」或「公司」，连同附属公司统称「集团」）（股票编号：1177）公布截至2023年6月30日止6个月（「期内」）之未经审核财务业绩。 more info >> |
|
|
中國生物製藥（1177.HK）公佈2023中期業績 |
| 中國領先的創新研發驅動型醫藥集團—中國生物製藥有限公司（「中國生物製藥」或「公司」，連同附屬公司統稱「集團」）（股票編號：1177）公佈截至2023年6月30日止6個月（「期內」）之未經審核財務業績。 more info >> |
|
|
Sino Biopharmaceutical (1177.HK) Announces 2023 Interim Results |
| Sino Biopharmaceutical Limited ("Sino Biopharmaceutical" or the "Company", together with its subsidiaries, the "Group") (HKEX:1177), a leading innovation-driven pharmaceutical conglomerate in the PRC, has announced its unaudited interim results for the six months ended 30 June 2023 (the "Period"). more info >> |
|
| Friday, March 31, 2023 |
|
|
中国生物制药（1177.HK）公布2022全年业绩 |
| 中国领先的创新研发驱动型医药集团—中国生物制药有限公司（「中国生物制药」或「公司」，连同附属公司统称「集团」）（股票编号：1177）公布截至2022年12月31日止12个月之经审核财务业绩。 more info >> |
|
|
中國生物製藥（1177.HK）公佈2022全年業績 |
| 中國領先的創新研發驅動型醫藥集團—中國生物製藥有限公司（「中國生物製藥」或「公司」，連同附屬公司統稱「集團」）（股票編號：1177）公佈截至2022年12月31日止12個月之經審核財務業績。 more info >> |
|
|
Sino Biopharm (1177.HK) Announces 2022 Annual Results |
| Sino Biopharmaceutical Limited ("Sino Biopharm" or the "Company", together with its subsidiaries, the "Group") (HKEX:1177), a leading innovation-driven pharmaceutical conglomerate in the PRC, has announced its audited financial results for the year ended 31 December 2022. more info >> |
|
| Tuesday, August 23, 2022 |
|
|
中国生物制药（1177.HK）公布2022年中期业绩，收入上升5.9%至人民币151.94亿元 |
| 中国领先的创新研发驱动型医药集团—中国生物制药有限公司（「中国生物制药」或「公司」，连同附属公司统称「集团」）（股票编号：1177）公布截至2022年6月30日止六个月（「期内」）之未经审核财务业绩。 more info >> |
|
|
中國生物製藥（1177.HK）公布2022年中期業績，收入上升5.9%至人民幣151.94億元 |
| 中國領先的創新研發驅動型醫藥集團—中國生物製藥有限公司（「中國生物製藥」或「公司」，連同附屬公司統稱「集團」）（股票編號：1177）公布截至2022年6月30日止六個月（「期內」）之未經審核財務業績。 more info >> |
|
| Monday, November 30, 2020 |
|
|
中國生物製藥公佈2020年第三季度業績 |
| 中國領先的創新研發驅動型醫藥集團—中國生物製藥有限公司（「中國生物製藥」或「公司」，連同附屬公司統稱「集團」）（股票編號：1177）公佈截至2020年9月30日止九個月（「回顧期」）之未經審核財務業績。 more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
GA-ASI Announces Technology Investments From Blue Magic Netherlands
Apr 17, 2025 01:00 HKT/SGT
|
|
|
HODL 2025: Blockchain's Brightest Minds. All in Dubai
Apr 16, 2025 23:59 HKT/SGT
|
|
|
analytica Vietnam 2025 Concludes with Record-Breaking Attendance and Exhibitor Participation
Apr 16, 2025 23:55 HKT/SGT
|
|
|
Kincora Copper: Investor Briefing Webinar - Sixth Asset Level Agreement
Apr 16, 2025 23:44 HKT/SGT
|
|
|
Standard Chartered GBA Business Confidence Survey shows calm before tariff storm in Q1
Apr 16, 2025 22:26 HKT/SGT
|
|
|
InnoEX and Spring Electronics Fair attract some 88,000 global buyers
Apr 16, 2025 21:28: JST
|
|
|
InnoEX and Spring Electronics Fair attract some 88,000 global buyers
Apr 16, 2025 20:28 HKT/SGT
|
|
|
FXDyno's AI-Powered Wave Trading Set to Redefine Gold Trading
Apr 16, 2025 20:00: JST
|
|
|
FXDyno's AI-Powered Wave Trading Set to Redefine Gold Trading
Apr 16, 2025 19:00 HKT/SGT
|
|
|
Global Logistics Industry Revolution, Reitar Logtech Launches the First Humanoid Logistics Robot
Apr 16, 2025 17:37 HKT/SGT
|
|
|
全球物流業大革新 域塔物流科技推出首個人形物流機械人
Apr 16, 2025 17:18 HKT/SGT
|
|
|
'The Sound of Chunhyang Opens the World' - The 95th Namwon Chunhyang Festival to Kick Off on April 30
Apr 16, 2025 16:30: JST
|
|
|
全球物流业大革新 域塔物流科技推出首个人形物流机器人
Apr 16, 2025 16:12 HKT/SGT
|
|
|
'The Sound of Chunhyang Opens the World' - The 95th Namwon Chunhyang Festival to Kick Off on April 30
Apr 16, 2025 15:30 HKT/SGT
|
|
|
交易寶今年首季碩果纍纍 𢹂手各界共推金融科技創新 實現港無現金城市願景
Apr 16, 2025 14:40 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
